Spinocerebellar ataxia type 31

Spinocerebellar ataxia type 31 (SCA31), also known as autosomal dominant cerebellar ataxia, deafness, and narcolepsy (ADCA-DN) in some earlier classifications, is a rare inherited neurodegenerative disorder primarily affecting the cerebellum and its connections. SCA31 is caused by a complex pentanucleotide repeat insertion (TGGAA) in an intronic region of the BEAN1 (brain expressed, associated with Nedd4, 1) gene, also involving the TK2 (thymidine kinase 2) gene locus on chromosome 16q22.1. This condition has been predominantly identified in the Japanese population, where it represents one of the more common forms of autosomal dominant cerebellar ataxia. The hallmark clinical feature of SCA31 is progressive cerebellar ataxia, which manifests as slowly worsening gait unsteadiness, limb incoordination, and balance difficulties. Patients typically experience onset in middle to late adulthood, usually after age 45, though the age of onset can vary. Additional neurological features may include dysarthria (slurred speech), nystagmus (involuntary eye movements), and reduced or absent deep tendon reflexes. Hearing impairment has been reported in some patients. The disease tends to progress slowly compared to many other spinocerebellar ataxias, and patients often maintain the ability to walk for many years after symptom onset. Brain imaging typically reveals cerebellar atrophy, particularly affecting the superior vermis. There is currently no disease-modifying or curative treatment for SCA31. Management is supportive and symptomatic, focusing on physical therapy and rehabilitation to maintain mobility and balance, speech therapy for dysarthria, and occupational therapy to assist with daily activities. Assistive devices such as walkers or wheelchairs may become necessary as the disease progresses. Genetic counseling is recommended for affected individuals and their families given the autosomal dominant inheritance pattern.

Common questions about Spinocerebellar ataxia type 31